Brind.

Michael Howe was appointed Chief Executive Officer of Aspire Biopharma Holdings, Inc. on June 24, 2025.

1 report, 0 independent Updated Jun 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Michael Howe was appointed Chief Executive Officer of Aspire Biopharma Holdings, Inc. on June 24, 2025.

Who's involved

What this event is mainly about
Michael Howe

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Unknown outlet